Equities

Shanghai ZJ Bio-Tech Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai ZJ Bio-Tech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)20.93
  • Today's Change-0.11 / -0.52%
  • Shares traded1.86m
  • 1 Year change+24.81%
  • Beta1.1007
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai ZJ Bio-Tech Co Ltd is a China-based company primarily engaged in the research and development, production, and sales of molecular diagnostic reagents and instrument equipment. The Company’s main products are nucleic acid testing kits and molecular diagnostic instruments. The Company’s products are applied in areas such as public health emergencies, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company distributes its products within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)131.50m
  • Net income in CNY-143.83m
  • Incorporated2005
  • Employees285.00
  • Location
    Shanghai ZJ Bio-Tech Co LtdBuilding 26No.588 Xinjun Ring Road, Pujiang Hi-TechPark, Caohejing Development ZoneSHANGHAI 201114ChinaCHN
  • Phone+86 2 134635507
  • Fax+86 2 134635507
  • Websitehttps://www.liferiver.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chison Medical Technologies Co Ltd449.62m136.02m3.89bn536.0028.702.78--8.661.211.214.0012.490.28421.462.38--8.608.379.739.3058.9557.6030.2529.307.53--0.003561.61-3.134.86-4.085.972.596.96
Shanghai Kindly Enterprise Dev Gp Co Ltd2.28bn243.83m4.02bn3.89k16.431.51--1.760.55980.55985.226.110.54753.762.37585,641.906.367.579.8914.5432.4635.1211.6112.011.34--0.17625.53-7.794.47-6.754.83-8.090.00
Shanghai ZJ Bio-Tech Co Ltd131.50m-143.83m4.02bn285.00--1.19--30.58-0.7312-0.73120.697417.660.03440.55042.34461,420.70-3.7612.74-3.9014.1044.2657.49-109.3731.9222.65--0.055837.90-34.88-7.156.86---3.72--
Zhejiang Gongdong Medical Techno Co Ltd1.12bn102.20m4.18bn1.69k40.672.43--3.720.4660.4665.137.780.54656.123.84664,064.404.9614.205.9116.3729.1039.169.0720.482.65--0.097842.5114.3715.0657.288.611.39--
Jianerkang Medical Co Ltd988.21m103.17m4.35bn1.64k17.492.98--4.401.591.598.039.350.69614.544.50603,301.807.27--8.08--23.15--10.44--7.07--0.0146--1.18---2.69------
Data as of Feb 13 2026. Currency figures normalised to Shanghai ZJ Bio-Tech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

4.80%Per cent of shares held by top holders
HolderShares% Held
GF Fund Management Co., Ltd.as of 30 Jun 20254.82m2.51%
Rongtong Fund Management Co., Ltd.as of 30 Jun 20251.50m0.78%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025947.40k0.49%
China Merchants Fund Management Co., Ltd.as of 30 Jun 2025507.73k0.26%
Xinyuan Asset Management Co., Ltd.as of 30 Jun 2025391.01k0.20%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025365.07k0.19%
China Asset Management Co., Ltd.as of 30 Jun 2025361.03k0.19%
E Fund Management Co., Ltd.as of 30 Jun 2025194.71k0.10%
Gfund Management Co., Ltd.as of 30 Jun 202572.49k0.04%
Penghua Fund Management Co., Ltd.as of 30 Jun 202562.98k0.03%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.